NAD+ IV Drip in Dubai

NAD+ IV therapy has a well-established clinical safety profile at standard doses. The most commonly reported side effects during infusion are mild and transient: nausea, flushing, tightness in the chest or throat, and headache. These typically resolve by slowing the infusion rate. Serious adverse events are rare. All sessions at Aafiyah Care Clinic are administered by clinical staff with GP oversight.

For longevity and energy restoration purposes, an initial course of 4–6 sessions is typical. Some patients notice significant improvement after 2–3 sessions. Ongoing monthly maintenance sessions are common for sustained benefit. Your GP will advise based on your starting NAD+ levels and response.

Yes. We can include an intracellular NAD+ level assessment as part of your longevity biomarker panel. This gives a baseline and allows us to track change over your treatment course.

NAD+ IV therapy is typically classified as preventive or elective and is not covered by standard UAE insurance policies. We provide itemised receipts and can provide supporting clinical documentation for any insurer query.

Oral NAD+ precursors such as NMN and NR are converted to NAD+ via metabolic pathways in the gut and liver. Absorption and conversion rates vary significantly between individuals. Intravenous NAD+ bypasses this conversion entirely, delivering the molecule directly to the bloodstream with near-100% bioavailability. IV therapy is therefore more appropriate for patients seeking a rapid, measurable response.